GH Research (GHRS) Ownership - Who owns GH Research?
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression... Show more
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GHRS showed earnings on May 08, 2025. You can read more about the earnings report here.